FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2263993110> ?p ?o ?g. }

• W2263993110 endingPage "337" @default.
• W2263993110 startingPage "329" @default.
• W2263993110 abstract "Loss of protein BAF250a (ARID1A) expression is present in women with rectovaginal deep-infiltrating endometriosis (DIE) and endometriosis affecting the pelvic sentinel lymph nodes (PSLN). Partial loss of protein BAF250a was found in some of our patient samples, comprising all endometriosis entities, including rectovaginal DIE and endometriosis affecting the PSLN. Loss of BAF250a (BRG-associated factor 250a)/ARIDIA (AT-rich interactive domain 1A) protein expression was identified among endometriosis-associated ovarian carcinomas and ovarian endometriosis, and this phenomenon was described as a possible early event in the transformation of endometriosis into cancer. DIE affecting the bowel/rectovaginal site is the most aggressive presentation of endometriosis and its ‘risk’ of malignant transformation has not been studied so far. We evaluated the immunohistochemical expression of BAF250a protein in 70 samples from patients enrolled in this study who were surgically treated at a tertiary center, university Hospital. The samples submitted to investigation were from rectovaginal DIE (n= 25/30), endometriosis affecting the PSLN (n= 5/7), ovarian endometriosis (n= 20/20) and endometrium from patients without endometriosis used as controls (n= 20/20). Partial loss (i.e. in one tissue section some cells stained positive for BAF250a while other cells, usually an adjacent group, were negative) of BAF250a protein was identified in 36% (9/25) of rectovaginal DIE samples, 40% (2/5) of endometriosis lesions involving the PSLN, 30% (6/20) of endometriomas, and also in 25% (5/20) of endometrium from controls. We found no statistical correlation between occurrence of partial loss of BAF250a protein and the use or not of hormone medications (P = 0.106), cycle phase (P = 0.917) and stage of disease (P = 0.717). We only found partial loss of BAF250a protein expression, and in a small population of women, with relatively high frequency in all benign tissues assessed in the present analysis. Therefore, this finding alone should not be correlated directly with the risk of malignant transformation in these lesions. The occurrence of partial loss of BAF250a protein expression in women with rectovaginal DIE and endometriosis affecting the PSLN is described for the first time. The value of this finding as a predictor of malignant transformation in endometriosis must still be clarified and further studied in association with other molecular events, such as PTEN (phosphatase and tensin homolog) deletion and PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) mutation. We might then be able to identify in the future which patients with endometriosis are at higher risk of cancer. This study was supported by an internal Charité grant to the Endometriosis Research Center and the authors declare no conflicts of interest." @default.
• W2263993110 created "2016-06-24" @default.
• W2263993110 creator A5002787034 @default.
• W2263993110 creator A5005009777 @default.
• W2263993110 creator A5032085925 @default.
• W2263993110 creator A5036627839 @default.
• W2263993110 creator A5052454978 @default.
• W2263993110 creator A5061929970 @default.
• W2263993110 creator A5071533705 @default.
• W2263993110 date "2016-01-31" @default.
• W2263993110 modified "2023-09-30" @default.
• W2263993110 title "(Partial) Loss of BAF250a (<i>ARID1A</i>) in rectovaginal deep-infiltrating endometriosis, endometriomas and involved pelvic sentinel lymph nodes" @default.
• W2263993110 cites W1885849841 @default.
• W2263993110 cites W1978088642 @default.
• W2263993110 cites W1986223688 @default.
• W2263993110 cites W1987802826 @default.
• W2263993110 cites W1994553563 @default.
• W2263993110 cites W1999788820 @default.
• W2263993110 cites W2000331910 @default.
• W2263993110 cites W2003658996 @default.
• W2263993110 cites W2008271242 @default.
• W2263993110 cites W2013017387 @default.
• W2263993110 cites W2015065613 @default.
• W2263993110 cites W2017238311 @default.
• W2263993110 cites W2017903755 @default.
• W2263993110 cites W2020639636 @default.
• W2263993110 cites W2025427572 @default.
• W2263993110 cites W2031692395 @default.
• W2263993110 cites W2034852369 @default.
• W2263993110 cites W2037010328 @default.
• W2263993110 cites W2041440766 @default.
• W2263993110 cites W2043020964 @default.
• W2263993110 cites W2048122601 @default.
• W2263993110 cites W2051973719 @default.
• W2263993110 cites W2053154970 @default.
• W2263993110 cites W2054097842 @default.
• W2263993110 cites W2058836507 @default.
• W2263993110 cites W2060913593 @default.
• W2263993110 cites W2065847037 @default.
• W2263993110 cites W2075053675 @default.
• W2263993110 cites W2082381246 @default.
• W2263993110 cites W2084416450 @default.
• W2263993110 cites W2091495172 @default.
• W2263993110 cites W2091937588 @default.
• W2263993110 cites W2093242828 @default.
• W2263993110 cites W2104813651 @default.
• W2263993110 cites W2112227475 @default.
• W2263993110 cites W2124580217 @default.
• W2263993110 cites W2125681453 @default.
• W2263993110 cites W2129159987 @default.
• W2263993110 cites W2134906914 @default.
• W2263993110 cites W2149884503 @default.
• W2263993110 cites W2159878774 @default.
• W2263993110 cites W2161661150 @default.
• W2263993110 cites W2170679339 @default.
• W2263993110 cites W4211081176 @default.
• W2263993110 cites W744259578 @default.
• W2263993110 doi "https://doi.org/10.1093/molehr/gaw009" @default.
• W2263993110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26832958" @default.
• W2263993110 hasPublicationYear "2016" @default.
• W2263993110 type Work @default.
• W2263993110 sameAs 2263993110 @default.
• W2263993110 citedByCount "29" @default.
• W2263993110 countsByYear W22639931102017 @default.
• W2263993110 countsByYear W22639931102018 @default.
• W2263993110 countsByYear W22639931102019 @default.
• W2263993110 countsByYear W22639931102020 @default.
• W2263993110 countsByYear W22639931102021 @default.
• W2263993110 countsByYear W22639931102022 @default.
• W2263993110 countsByYear W22639931102023 @default.
• W2263993110 crossrefType "journal-article" @default.
• W2263993110 hasAuthorship W2263993110A5002787034 @default.
• W2263993110 hasAuthorship W2263993110A5005009777 @default.
• W2263993110 hasAuthorship W2263993110A5032085925 @default.
• W2263993110 hasAuthorship W2263993110A5036627839 @default.
• W2263993110 hasAuthorship W2263993110A5052454978 @default.
• W2263993110 hasAuthorship W2263993110A5061929970 @default.
• W2263993110 hasAuthorship W2263993110A5071533705 @default.
• W2263993110 hasBestOaLocation W22639931101 @default.
• W2263993110 hasConcept C104317684 @default.
• W2263993110 hasConcept C126322002 @default.
• W2263993110 hasConcept C142724271 @default.
• W2263993110 hasConcept C2779522080 @default.
• W2263993110 hasConcept C2779742232 @default.
• W2263993110 hasConcept C2781273526 @default.
• W2263993110 hasConcept C501734568 @default.
• W2263993110 hasConcept C55493867 @default.
• W2263993110 hasConcept C71924100 @default.
• W2263993110 hasConcept C86803240 @default.
• W2263993110 hasConceptScore W2263993110C104317684 @default.
• W2263993110 hasConceptScore W2263993110C126322002 @default.
• W2263993110 hasConceptScore W2263993110C142724271 @default.
• W2263993110 hasConceptScore W2263993110C2779522080 @default.
• W2263993110 hasConceptScore W2263993110C2779742232 @default.
• W2263993110 hasConceptScore W2263993110C2781273526 @default.
• W2263993110 hasConceptScore W2263993110C501734568 @default.
• W2263993110 hasConceptScore W2263993110C55493867 @default.
• W2263993110 hasConceptScore W2263993110C71924100 @default.

• next